A longitudinal study measuring DAT availability before and after a long‐term MPH treatment in drug‐naive ADHD patients demonstrated increased DAT availability after long‐term MPH treatment, indicating that DAT adapts to synaptic dopamine levels and that chronic MPH treatment may result in upward regulation of DAT availability.16 This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.